The papillomavirus (PV) E2 protein is an important regulator of the viral life cycle. It has diverse roles in viral transcription, DNA replication, and genome maintenance. Our laboratory has previously identified the cellular bromodomain protein Brd4 as a key interacting partner of E2. Brd4 mediates the transcriptional activation function of E2 and plays an important role in viral genome maintenance in dividing cells. E2 interacts with the C-terminal domain (CTD) of Brd4, and the CTD functions in a dominant-negative manner through binding E2 and interfering with E2's interaction with the full-length Brd4 protein. Previous studies have shown that PV E2 proteins are short lived; however, the mechanisms regulating their stability and degradation have not yet been well established. In this study, we explored the role of Brd4 in the regulation of bovine PV 1 (BPV1) and human PV 16 (HPV16) E2 stability. Expression of the Brd4 CTD dramatically increases E2 levels. Both BPV1 E2 and HPV16 E2 are regulated by ubiquitylation, and Brd4 CTD expression blocks this ubiquitylation, thus stabilizing the E2 protein. Furthermore, we have identified the cullin-based E3 ligases and specifically cullin-3 as potential components of the ubiquitylation machinery that targets both BPV1 and HPV16 E2 for ubiquitylation. Expression of the Brd4 CTD blocks the interaction between E2 and the cullin-3 complex. In addition to Brd4's role in mediating E2 transcription and genome tethering activities, these data suggest a potential role for Brd4 in regulating E2 stability and protein levels within PV-infected cells.Papillomaviruses (PVs) are small, double-stranded DNA tumor viruses that infect squamous epithelial cells. Their life cycle is closely linked to the differentiation program of these cells (15). The full-length PV E2 protein has several roles in the viral life cycle (15). Together with the viral E1 helicase, E2 initiates origin-specific viral DNA replication. Through its ability to link viral genomes to host chromosomes during mitosis, E2 is also required for viral genome maintenance. In addition, E2 is an important regulator of viral transcription. The structure of the E2 protein resembles that of a prototypical transcription factor, with an amino-terminal transcriptional activation domain and a carboxy-terminal DNA binding and dimerization domain separated by a less well-conserved hinge region. Depending upon the location of its cognate DNA binding sites within the promoter region, E2 can act either as a transcriptional activator or as a repressor. For the high-risk human PVs (HPVs), including HPV16 and HPV18, E2 represses expression from the LCR promoter that controls expression of the E6 and E7 viral oncogenes (33). During progression to cervical cancer, the HPV DNA is frequently integrated into the host cellular chromosomes in a manner that abolishes E2 expression, thus leading to increased E6 and E7 expression. The deregulated expression of the E6 and E7 oncogenes is thought to be a critical step in HPV-mediated transformation and ...